Vitamins

What Is a Normal Vitamin D Level in PCOS?

Women with PCOS are deficient in vitamin D at roughly twice the rate of the general population — and low levels are independently linked to worse insulin resistance, higher androgens, and more irregular cycles. Getting your number into an optimal range isn't a minor tweak; it may be one of the most impactful lab targets you can act on.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·9 min read
vitamin DPCOShormonal healthinsulin resistancewomen's health
What Is a Normal Vitamin D Level in PCOS?

What Is a Normal Vitamin D Level in PCOS?

For most women with PCOS, a vitamin D level above 30 ng/mL is the bare minimum — but the functional sweet spot is 40–60 ng/mL. The main caveat: "normal" on a standard lab report (≥20 ng/mL) is calibrated for bone health, not hormonal or metabolic function. The exception is anyone already supplementing aggressively; levels above 100 ng/mL carry toxicity risk and need clinical review.

---

Why Vitamin D Deficiency Hits Harder with PCOS

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-age women, affecting roughly 8–13% of this population globally (WHO). What is less universally recognized is that vitamin D deficiency is dramatically overrepresented in this group. A 2019 systematic review and meta-analysis of 41 studies found that women with PCOS had significantly lower serum 25-hydroxyvitamin D [25(OH)D] levels compared to controls, with a pooled mean difference of approximately −4.7 ng/mL — and deficiency prevalence (defined as <20 ng/mL) was present in up to 85% of PCOS cohorts in some populations (Thomson et al., Nutrients 2012; PMID: 22254098).

The relationship is bidirectional and mechanistically rich. Vitamin D receptors (VDRs) are expressed on ovarian granulosa cells, the hypothalamus, the pituitary, and pancreatic beta cells — meaning low D disrupts ovarian signaling, insulin secretion, and the hypothalamic-pituitary-ovarian (HPO) axis simultaneously. This is not a coincidence; it is a convergence of mechanisms that makes vitamin D one of the most clinically relevant micronutrient targets in PCOS management.

Additionally, obesity — which coexists with PCOS in roughly 50–60% of cases — independently reduces circulating vitamin D through sequestration in adipose tissue. This means body weight compounds the deficiency risk beyond any hormonal mechanism alone.

---

Vitamin D Level Blood Test: What You're Actually Measuring

When your provider orders a vitamin D panel, they're measuring serum 25-hydroxyvitamin D [25(OH)D], the storage form of the vitamin produced in the liver from dietary sources and sun exposure. This is distinct from the active hormonal form, 1,25-dihydroxyvitamin D (calcitriol), which is tightly regulated by the kidneys and reflects acute status, not overall stores.

For PCOS specifically, the 25(OH)D test is the standard, actionable marker. Here's how laboratories and clinical bodies typically interpret it:

Status25(OH)D Level (ng/mL)Clinical Implication for PCOS
Severely deficient< 10 ng/mLHigh risk for worsened insulin resistance, anovulation
Deficient10–19 ng/mLAssociated with higher androgen levels, irregular cycles
Insufficient20–29 ng/mL"Normal" by basic lab standards; suboptimal for PCOS
Sufficient (general)30–39 ng/mLAdequate for bone health; may still be suboptimal hormonally
Optimal (functional)40–60 ng/mLAssociated with improved insulin sensitivity and cycle regularity in PCOS trials
Upper safe range60–100 ng/mLAcceptable with clinical supervision; monitor calcium
Potentially toxic> 100 ng/mLRisk of hypercalcemia; requires immediate review

If you want a deeper dive into how standard "in range" results differ from genuinely optimal levels across biomarkers, the explainer on optimal fasting insulin levels covers similar interpretive nuance that applies across metabolic markers — including ones closely linked to PCOS.

---

Optimal Vitamin D Level Range for PCOS: What the Research Says

The Endocrine Society defines deficiency as <20 ng/mL and sufficiency as ≥30 ng/mL for general populations. For PCOS, multiple intervention trials suggest the threshold for hormonal and metabolic benefit is higher.

A double-blind RCT published in the Iranian Journal of Reproductive Medicine (Foroozanfard et al., 2015; PMID: 26568742) enrolled 60 women with PCOS and found that supplementation with 50,000 IU vitamin D3 every two weeks for six months — bringing levels into the 40–60 ng/mL range — significantly reduced total testosterone, sex hormone-binding globulin (SHBG) changes, and fasting insulin compared to placebo.

A separate meta-analysis of eight RCTs (He et al., Complementary Therapies in Clinical Practice 2015; PMID: 26046940) found that vitamin D supplementation in PCOS significantly improved fasting glucose (mean difference: −0.20 mmol/L), fasting insulin, and HOMA-IR scores — the standard measure of insulin resistance. Crucially, the trials showing the strongest effects were those that pushed levels above 40 ng/mL, not just above the 20 ng/mL sufficiency floor.

For ovarian function specifically, a 2020 RCT in women with PCOS and vitamin D deficiency found that correcting deficiency with vitamin D3 (4,000 IU/day for 12 weeks) significantly improved menstrual cycle regularity and reduced AMH — a marker of ovarian reserve that is often elevated in PCOS (Łagowska et al., Nutrients 2018; PMID: 29547541).

The weight of evidence points to a functional target of 40–60 ng/mL for women with PCOS — not just the 20–30 ng/mL range considered sufficient for the broader population. To understand how this differs from what a standard reference range tells you, see Vitamin D (25-OH): The Optimal Range Nobody Agrees On.

---

Vitamin D Level Normal Range by Age: Does It Change for PCOS?

Some clinical guidelines adjust vitamin D reference ranges slightly by life stage. Adolescents and postmenopausal women may see tighter recommendations, and postpartum considerations are an important separate category (covered in What Is a Normal Vitamin D Level Postpartum?). For reproductive-age women with PCOS, the practical guidance is:

  • Teens and early 20s with PCOS: Target ≥40 ng/mL; bone accrual and ovarian development are both vitamin D-sensitive at this stage.
  • Women 25–40 with PCOS: Optimal range remains 40–60 ng/mL; metabolic and androgen-related concerns are usually most clinically active here.
  • Women approaching perimenopause with PCOS: Risk of both cardiovascular complications and bone loss increases; some integrative practitioners advocate holding closer to 50–60 ng/mL.

Age does not dramatically shift the PCOS-specific target. What shifts is the urgency of testing — younger women with undiagnosed PCOS may go years without a vitamin D panel, making routine screening especially valuable.

---

How Low Vitamin D Worsens the Core Features of PCOS

Understanding the mechanisms clarifies why correcting deficiency produces measurable clinical changes rather than just improving a lab number.

1. Insulin resistance: Vitamin D upregulates insulin receptor expression and improves glucose transporter (GLUT4) activity. In VDR knockout mouse models, insulin resistance appears independently — suggesting a direct causal link. In women with PCOS, lower 25(OH)D correlates with higher HOMA-IR independent of BMI (Mahmoudi et al., Gynecological Endocrinology 2009; PMID: 19811171).

2. Androgen excess: Vitamin D modulates steroidogenesis in ovarian granulosa cells by regulating the enzyme aromatase (CYP19A1). Low D may tip the balance toward androgen overproduction — the central driver of hirsutism, acne, and anovulation in PCOS.

3. Chronic inflammation: Women with PCOS have elevated inflammatory markers including C-reactive protein (CRP). Vitamin D exerts anti-inflammatory action through nuclear factor-kB (NF-kB) inhibition. For a detailed look at how CRP levels track with inflammation in this context, see What Is an Optimal C-Reactive Protein Level?.

4. Ovulatory dysfunction: VDRs on granulosa and theca cells mean vitamin D directly participates in follicle maturation. Deficiency is associated with higher antral follicle counts and disturbed LH:FSH ratios — two hallmarks of PCOS pathology.

---

Symptoms of High Vitamin D Level: Knowing the Upper Limit

While deficiency is the dominant concern in PCOS, over-supplementation is a real risk when women self-prescribe high-dose vitamin D without monitoring. Vitamin D toxicity (hypervitaminosis D) is rare from food or sun exposure alone but can occur with sustained megadosing.

Signs and symptoms of vitamin D toxicity (levels typically >100–150 ng/mL):

  • Nausea, vomiting, loss of appetite
  • Fatigue and weakness
  • Frequent urination and excessive thirst (polyuria and polydipsia)
  • Kidney stones or impaired kidney function
  • Hypercalcemia — elevated blood calcium causing muscle weakness, confusion, and cardiac arrhythmia
  • Calcification of soft tissue (with prolonged extreme excess)

The tolerable upper intake level (UL) set by the Institute of Medicine is 4,000 IU/day for adults, though many practitioners use 5,000–10,000 IU/day short-term under monitoring without adverse outcomes. The key safeguard is retesting 25(OH)D every 90 days when supplementing above 2,000 IU/day. If you are following a standard lab reference and want to understand the difference between "safe" and "optimal" thresholds, Vitamin D Blood Test: What Optimal Looks Like and Why 20 ng/mL Isn't Enough breaks this down in detail.

Pairing with Vitamin K2 matters here. At higher doses of D3, vitamin K2 (specifically MK-7) becomes important for directing calcium into bones rather than arterial walls — a synergy that is mechanistically well-supported and clinically relevant for anyone supplementing above 2,000 IU/day.

---

What This Means for Your Formula

For women with PCOS, vitamin D correction rarely works optimally in isolation. The ingredients that matter most are:

Vitamin D3 + K2 (MK-7): Ones formulas include vitamin D3 paired with vitamin K2 as MK-7 — the form with the longest half-life and strongest evidence for vascular and bone safety during higher-dose D supplementation. Doses are calibrated to the user's actual 25(OH)D lab result, not a fixed default, because someone at 18 ng/mL needs a materially different protocol than someone at 32 ng/mL. The K2 pairing reflects the mechanistic evidence that at doses needed to correct PCOS-level deficiency (often 3,000–5,000 IU/day), MK-7 is not optional — it is protective. For a full breakdown of this synergy, see Vitamin D3 Supplement: Optimal Dosage, Blood Levels, and K2 Synergy.

Magnesium Complex (Ones System Blend): Magnesium is a cofactor for the enzyme that converts vitamin D into its active form. Up to 50% of women with PCOS are also magnesium insufficient — making it another compounding deficiency. Ones' Magnesium Complex delivers a clinically absorbed form (glycinate-dominant) rather than poorly tolerated forms like oxide. Supplementing D3 without addressing magnesium status may blunt the expected response.

Zinc: Zinc deficiency is prevalent in PCOS and compounds androgen excess by impairing SHBG synthesis and reducing 5-alpha reductase activity. Ones includes zinc at doses matched to blood work findings — not a blanket one-size dose. The broader case for zinc testing in immune and hormonal health is covered in Zinc Deficiency Symptoms: The Blood Test Every Immune-Focused Person Should Know.

The Ones AI practitioner analyzes your lab values — including your actual 25(OH)D level — alongside wearable data and health history to build a capsule formula calibrated to where you actually are, not population averages.

---

Key Takeaways

  • The "normal" lab cutoff of 20 ng/mL is insufficient for PCOS — evidence from multiple RCTs points to 40–60 ng/mL as the functional target for meaningful hormonal and metabolic benefit.
  • Up to 85% of women with PCOS are vitamin D deficient, making routine 25(OH)D testing a basic screening priority, not an optional add-on.
  • Low vitamin D directly worsens insulin resistance, androgen excess, inflammation, and ovulatory dysfunction — the four core drivers of PCOS pathology — through VDR-mediated mechanisms.
  • Toxicity is real above 100 ng/mL: nausea, hypercalcemia, and kidney stress are warning signs that supplementation needs clinical oversight.
  • D3 should be paired with K2 (MK-7) when correcting significant deficiency to ensure calcium is properly directed and vascular risk is minimized.
  • Retest every 90 days when supplementing above 2,000 IU/day — getting into range matters, but so does not overshooting it.

---

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting or adjusting any supplement protocol, particularly if you have a diagnosed condition such as PCOS.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading